• Compatibility Tests (Crossmatch), ABO, Rh Typing
  • Immunohistochemistry for Burkitt lymphoma panel CD20, CD10, BCL-6, BCL-2, Ki-67.
  • Leishmania (Visceral Leishmaniasis) Antibody, IgG
  • Inflammatory Bowel Disease Serology Panel, Serum
  • Haptoglobin
  • Quinidine, Urine
  • Protein S Activity
  • ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
  • Phosphorylated tau 217 (pTau 217), Plasma, (Quest AD-Detect®, ALZpath pTau217)
  • Catecholamine Fractionation, Free, 24 Hour, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Specimen Collection
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.